Alpine Group USVI LLC Takes $448,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Alpine Group USVI LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,878 shares of the exchange traded fund’s stock, valued at approximately $448,000.

Other large investors have also recently modified their holdings of the company. Quattro Financial Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $32,000. NEXT Financial Group Inc grew its holdings in shares of SPDR S&P Biotech ETF by 22,933.3% during the 2nd quarter. NEXT Financial Group Inc now owns 691 shares of the exchange traded fund’s stock valued at $61,000 after purchasing an additional 688 shares during the last quarter. Stonebridge Capital Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $62,000. Family Management Corp bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $101,000. Finally, Advisory Services Network LLC grew its holdings in shares of SPDR S&P Biotech ETF by 51.2% during the 2nd quarter. Advisory Services Network LLC now owns 1,229 shares of the exchange traded fund’s stock valued at $108,000 after purchasing an additional 416 shares during the last quarter.

Shares of SPDR S&P Biotech ETF stock traded up $1.10 during midday trading on Friday, hitting $77.15. 439,348 shares of the company traded hands, compared to its average volume of 4,732,436. The firm’s fifty day moving average price is $79.59 and its 200-day moving average price is $83.99. SPDR S&P Biotech ETF has a 12 month low of $64.38 and a 12 month high of $93.87.

The business also recently declared a — dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 23rd were issued a dividend of $0.0032 per share. This represents a dividend yield of 0.1%. The ex-dividend date of this dividend was Friday, September 20th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: What is the formula for the cash asset ratio?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.